SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's signs pact with R-Pharm of Russia

22 Dec 2010 Evaluate

Dr Reddy's Laboratories Ltd has entered into a licensing, technology transfer; manufacturing and marketing agreement with R-Pharm of Russia. The collaboration is in the area of high-technology and works on a profit-sharing model. It will entail licensing of manufacturing know-how of products by Dr Reddy's, local manufacturing of products in Russia, co-development of high technology products and knowledge sharing between both parties at regular intervals.crackcrack

Dr. Reddys Lab Share Price

1279.25 5.35 (0.42%)
15-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.45
Dr. Reddys Lab 1279.25
Cipla 1381.50
Zydus Lifesciences 1087.75
Lupin 2273.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: